fda import alert 66-80 green list glp-1 apis Targets and Peptide Compounding, Advertising and 'Research Use Only' Labeling 行业研究| FDA针对GLP-1原料药出台“Green List”（绿名单）医药新闻-ByDrug-一站式医药资源共享中心-医药魔方

Summers first book, Living Your Healthiest Semaglutide Life, will be published in July 2025

[38] suggested that obese patients treated with liraglutide or Semaglutide showed a marked reduction in self-reported alcohol intake after 36 months, particularly among high consumers

The choice of delivery method matters more than most people realize

The analysis, conducted between December 2025 and January 2026, was part of an ongoing cross-sectional study examining GLP-1 RA use among people with eating disorders in the US

plus medical treatments including mole removal, thread vein treatment and excessive sweating injections